To those who have been involved in glioblastoma research in the past, I am sure that you understand the basics. For those who do now know, what you should know is that gliomas are looked at in the medical field as some of the most common tumors in the brain as well as the most aggressive seen. As a result, research efforts are made with them being seen at the center. With so much work to be done, I feel as though gene mutations and relations alike are going to be focused on.
An article on BioNews Texas spoke about how there were a number of new findings related to glioblastoma multiforme, which is something that researchers have focused on and for good reasons. The report said that, in 2013, there are about 23,000 cases of this condition being expected and most patients pass away within 15 months of diagnosis. As you can imagine, there has been work done in order to make better sense of this condition. What has come to the surface as a result of such efforts?
Professor as well as the chair of the Cancer Genome Atlas, Lynda Chin, M.D., spoke about the findings that came about following a sojourn of five years. There has been quite a bit of data that has been uncovered and I think that there are many ways it could be put into practice. Such information has been able to detail such things as genetic mutations, deletions, and what have you. I think that, if such knowledge is put into effect, more effective therapies stand a strong chance of coming about.
I believe that past mutations have to be looked to as well, a point that is supported by organizations along the lines of Voices against Brain Cancer. Keep in mind that there are many individuals who have been involved in the realm of glioblastoma research and they can tell you about the many findings related to genes. The report said that 61 mutated genes have been newly discovered and one of the more interesting points of information had to do with the epidermal growth factor receptor. For those who do not know, the EGFR gene was seen as mutated in 57% of these tumors.
Considering all of the work that has been seen glioblastoma research so far, it's clear that these particular tumors have been given tremendous attention. They are some of the most complicated growths you can imagine and they are going to vary in many ways from one patient to the next. The ability to pinpoint certain genes, though, can lend a greater assist to the methods conducted in the way of research. My only hope is that this kind of information will make therapies in place even better.
An article on BioNews Texas spoke about how there were a number of new findings related to glioblastoma multiforme, which is something that researchers have focused on and for good reasons. The report said that, in 2013, there are about 23,000 cases of this condition being expected and most patients pass away within 15 months of diagnosis. As you can imagine, there has been work done in order to make better sense of this condition. What has come to the surface as a result of such efforts?
Professor as well as the chair of the Cancer Genome Atlas, Lynda Chin, M.D., spoke about the findings that came about following a sojourn of five years. There has been quite a bit of data that has been uncovered and I think that there are many ways it could be put into practice. Such information has been able to detail such things as genetic mutations, deletions, and what have you. I think that, if such knowledge is put into effect, more effective therapies stand a strong chance of coming about.
I believe that past mutations have to be looked to as well, a point that is supported by organizations along the lines of Voices against Brain Cancer. Keep in mind that there are many individuals who have been involved in the realm of glioblastoma research and they can tell you about the many findings related to genes. The report said that 61 mutated genes have been newly discovered and one of the more interesting points of information had to do with the epidermal growth factor receptor. For those who do not know, the EGFR gene was seen as mutated in 57% of these tumors.
Considering all of the work that has been seen glioblastoma research so far, it's clear that these particular tumors have been given tremendous attention. They are some of the most complicated growths you can imagine and they are going to vary in many ways from one patient to the next. The ability to pinpoint certain genes, though, can lend a greater assist to the methods conducted in the way of research. My only hope is that this kind of information will make therapies in place even better.
About the Author:
Contact Voices Against Brain Cancer if you're seeking more information about glioblastoma research.. This article, Changing Genes & The Work Of Glioblastoma Research has free reprint rights.
0 comments: